Practical Approaches to the Use of Lenalidomide in Multiple Myeloma: A Canadian Consensus

In Canada, lenalidomide combined with dexamethasone (Len/Dex) is approved for use in relapsed or refractory multiple myeloma (RRMM). Our expert panel sought to provide an up-to-date practical guide on the use of lenalidomide in the managing RRMM within the Canadian clinical setting, including manage...

Descripción completa

Detalles Bibliográficos
Autores principales: Reece, Donna, Kouroukis, C. Tom, LeBlanc, Richard, Sebag, Michael, Song, Kevin, Ashkenas, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2012
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477526/
https://www.ncbi.nlm.nih.gov/pubmed/23097669
http://dx.doi.org/10.1155/2012/621958

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477526/
https://www.ncbi.nlm.nih.gov/pubmed/23097669
http://dx.doi.org/10.1155/2012/621958

Ejemplares similares